Rana Anish, Dourlain Jordan, Miccio Robin, Silliman-Cohen Tiffany, Evans Jennifer, Rosoff-Verbit Zoe, Erlichman Jessi, Wang Xingmei, Mascarenhas Maria, Benitez Alain
Children's Hospital of Philadelphia, Department of Gastroenterology, Hepatology, and Nutrition, Integrative Health Program, Philadelphia, USA.
Int J Ther Massage Bodywork. 2024 Dec 12;17(4):27-42. doi: 10.3822/ijtmb.v17i4.1035. eCollection 2024 Dec.
Myofascial release (MFR) is a form of massage therapy that involves identifying and releasing restrictions in the fascia and muscles. MFR-like techniques have shown improvement in abdominal pain, distention, constipation, and quality of life (QoL) in adults. Therefore, MFR may be helpful in patients with irritable bowel syndrome (IBS), a disorder of gut-brain interaction or functional gastrointestinal disorder, mainly presenting with prolonged abdominal pain, bloating, and altered defecation patterns, leading to impairment in QoL. Treatments for IBS are limited and do not always completely relieve pain. To date, no studies have evaluated the feasibility and acceptability of MFR for children with IBS as a potential therapy.
The aim of the study is to assess the feasibility and acceptability of administering abdominal wall-targeted MFR in children with IBS.
This study was approved and conducted at Children's Hospital of Philadelphia.
Males and females aged 13-18 years meeting Rome IV criteria for IBS were included in the study.
Participants underwent six 1-h weekly sessions of abdominal wall-targeted MFR with a licensed massage therapist (LMT) and performed self-MFR at home between sessions. Feasibility and acceptability data were collected via REDCap (Research Electronic Data Capture) by the study team and LMTs. Symptoms and QoL were assessed before and after the intervention period using child and parent versions of validated pediatric questionnaires.
Of 10 participants aged 14-18 years, 60% females underwent the MFR intervention and completed the 6-week protocol. The median visit compliance with questionnaire completion was 90%. All participants received self-MFR education and performed self-MFR between sessions. Fascia restrictions were identified and released in all participants, as reported by the LMTs. Most participants voluntarily provided positive feedback on MFR. All participants reported no or minimal soreness during or after MFR, and no adverse events were reported.
Abdominal wall-targeted MFR is feasible to administer and well accepted in pediatric IBS patients.
肌筋膜放松（MFR）是一种按摩疗法，包括识别和解除筋膜及肌肉中的限制。类似MFR的技术已显示可改善成人的腹痛、腹胀、便秘及生活质量（QoL）。因此，MFR可能对肠易激综合征（IBS）患者有益，IBS是一种肠脑交互障碍或功能性胃肠疾病，主要表现为长期腹痛、腹胀及排便习惯改变，导致生活质量受损。IBS的治疗方法有限，且并不总能完全缓解疼痛。迄今为止，尚无研究评估MFR作为一种潜在疗法对IBS儿童的可行性和可接受性。
本研究的目的是评估对IBS儿童实施腹壁靶向MFR的可行性和可接受性。
本研究在费城儿童医院获得批准并开展。
符合罗马IV标准的13 - 18岁IBS男性和女性纳入本研究。
参与者每周接受6次、每次1小时的腹壁靶向MFR治疗，由持牌按摩治疗师（LMT）进行操作，且在疗程之间在家中自行进行MFR。研究团队和LMT通过REDCap（研究电子数据采集）收集可行性和可接受性数据。在干预期前后，使用经过验证的儿科问卷的儿童版和家长版评估症状和生活质量。
10名年龄在14 - 18岁的参与者中，60%为女性，接受了MFR干预并完成了为期6周的方案。问卷完成情况的访视依从性中位数为90%。所有参与者均接受了自我MFR教育，并在疗程之间进行自我MFR。LMT报告称，所有参与者均识别并解除了筋膜限制。大多数参与者自愿对MFR给予积极反馈。所有参与者均报告在MFR期间或之后无疼痛或仅有轻微疼痛，且未报告不良事件。
腹壁靶向MFR对儿科IBS患者实施可行且接受度良好。
